These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Oral immunotherapy and potential treatment. Sato S; Yanagida N; Ebisawa M Chem Immunol Allergy; 2015; 101():106-13. PubMed ID: 26022870 [TBL] [Abstract][Full Text] [Related]
3. The Use of Omalizumab in Food Oral Immunotherapy. Labrosse R; Graham F; Des Roches A; Bégin P Arch Immunol Ther Exp (Warsz); 2017 Jun; 65(3):189-199. PubMed ID: 27628022 [TBL] [Abstract][Full Text] [Related]
5. Immunotherapy in food allergy: towards new strategies. Sato S; Yanagida N; Ogura K; Asaumi T; Okada Y; Koike Y; Iikura K; Syukuya A; Ebisawa M Asian Pac J Allergy Immunol; 2014 Sep; 32(3):195-202. PubMed ID: 25268336 [TBL] [Abstract][Full Text] [Related]
6. Clinical aspects of oral immunotherapy for the treatment of allergies. Yanagida N; Sato S; Ebisawa M Semin Immunol; 2017 Apr; 30():45-51. PubMed ID: 28780220 [TBL] [Abstract][Full Text] [Related]
7. Mechanistic correlates of clinical responses to omalizumab in the setting of oral immunotherapy for milk allergy. Frischmeyer-Guerrerio PA; Masilamani M; Gu W; Brittain E; Wood R; Kim J; Nadeau K; Jarvinen KM; Grishin A; Lindblad R; Sampson HA J Allergy Clin Immunol; 2017 Oct; 140(4):1043-1053.e8. PubMed ID: 28414061 [TBL] [Abstract][Full Text] [Related]
8. Combining Anti-IgE Monoclonal Antibodies and Oral Immunotherapy for the Treatment of Food Allergy. Guilleminault L; Michelet M; Reber LL Clin Rev Allergy Immunol; 2022 Feb; 62(1):216-231. PubMed ID: 34550555 [TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy. Wood RA; Kim JS; Lindblad R; Nadeau K; Henning AK; Dawson P; Plaut M; Sampson HA J Allergy Clin Immunol; 2016 Apr; 137(4):1103-1110.e11. PubMed ID: 26581915 [TBL] [Abstract][Full Text] [Related]
11. Clinical studies in oral allergen-specific immunotherapy: differences among allergens. Sato S; Yanagida N; Ogura K; Imai T; Utsunomiya T; Iikura K; Goto M; Asaumi T; Okada Y; Koike Y; Syukuya A; Ebisawa M Int Arch Allergy Immunol; 2014; 164(1):1-9. PubMed ID: 24943470 [TBL] [Abstract][Full Text] [Related]
12. Omalizumab in children with severe allergic disease: a case series. Crisafulli G; Caminiti L; Chiera F; Arasi S; Salzano G; Panasiti I; Barbalace A; Pajno GB Ital J Pediatr; 2019 Jan; 45(1):13. PubMed ID: 30642367 [TBL] [Abstract][Full Text] [Related]